Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 13, 2015
Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration
Yue-Yun To, Kimberly J Sutcliffe, Helena M Hoen, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2014
Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program
Roxanne Payne, Lyn Glenn, Helena Hoen, et al.
Clinical Immunology (Orlando, Fla.)
|
July 20, 2005
Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patients
Todd S Crocenzi, Christopher P G Tretter, Thomas Schwaab, et al.
Annals of Surgical Oncology
|
June 3, 2022
Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin
Robert C G Martin, Kerri A Simo, Paul Hansen, et al.
Cancer
|
July 8, 2015
Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis
Robert C G Martin, Charles R Scoggins, Marshall Schreeder, et al.
The Annals of Thoracic Surgery
|
November 27, 2018
Expert Consensus Document on Pulmonary Metastasectomy
John R Handy, Ross M Bremner, Todd S Crocenzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer
Sandra L Wong, Pamela B Mangu, Michael A Choti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery
Krishna S Gunturu, Kenneth R Meehan, Todd A Mackenzie, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 23, 2013
A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study
Uday B Dandamudi, Musie Ghebremichael, Jeffrey A Sosman, et al.
Annals of Surgery
|
May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer
Michael A Morse, Donna Niedzwiecki, John L Marshall, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 13, 2015
Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration
Yue-Yun To, Kimberly J Sutcliffe, Helena M Hoen, et al.
Journal for Immunotherapy of Cancer
|
May 24, 2014
Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program
Roxanne Payne, Lyn Glenn, Helena Hoen, et al.
Clinical Immunology (Orlando, Fla.)
|
July 20, 2005
Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patients
Todd S Crocenzi, Christopher P G Tretter, Thomas Schwaab, et al.
Annals of Surgical Oncology
|
June 3, 2022
Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin
Robert C G Martin, Kerri A Simo, Paul Hansen, et al.
Cancer
|
July 8, 2015
Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis
Robert C G Martin, Charles R Scoggins, Marshall Schreeder, et al.
The Annals of Thoracic Surgery
|
November 27, 2018
Expert Consensus Document on Pulmonary Metastasectomy
John R Handy, Ross M Bremner, Todd S Crocenzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer
Sandra L Wong, Pamela B Mangu, Michael A Choti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery
Krishna S Gunturu, Kenneth R Meehan, Todd A Mackenzie, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
October 23, 2013
A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study
Uday B Dandamudi, Musie Ghebremichael, Jeffrey A Sosman, et al.
Annals of Surgery
|
May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer
Michael A Morse, Donna Niedzwiecki, John L Marshall, et al.
Page
of 2